267 related articles for article (PubMed ID: 28631017)
21. Proton beam therapy of parapapillary choroidal melanoma.
Riechardt AI; Cordini D; Willerding GD; Georgieva I; Weber A; Seibel I; Lakotka N; Bechrakis NE; Foerster MH; Moser L; Joussen AM
Am J Ophthalmol; 2014 Jun; 157(6):1258-65. PubMed ID: 24548873
[TBL] [Abstract][Full Text] [Related]
22. Side Effects of Proton Beam Radiotherapy Treatment on Iris Melanoma.
Eibenberger K; Heimann H; Gatchalian L; Kacperek A; Hussain R
Ophthalmology; 2023 Sep; 130(9):958-965. PubMed ID: 37169262
[TBL] [Abstract][Full Text] [Related]
23. Limbal Stem Cell Preservation During Proton Beam Irradiation for Diffuse Iris Melanoma.
Singh AD; Dupps WJ; Biscotti CV; Suh JH; Lathrop KL; Nairn JP; Shih H
Cornea; 2017 Jan; 36(1):119-122. PubMed ID: 27755196
[TBL] [Abstract][Full Text] [Related]
24. Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma.
Wuestemeyer H; Sauerwein W; Meller D; Chauvel P; Schueler A; Steuhl KP; Bornfeld N; Anastassiou G
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):438-46. PubMed ID: 16133022
[TBL] [Abstract][Full Text] [Related]
25. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma.
Kanemoto A; Mizumoto M; Okumura T; Takahashi H; Hashimoto T; Oshiro Y; Fukumitsu N; Moritake T; Tsuboi K; Sakae T; Sakurai H
Acta Oncol; 2013 Apr; 52(3):538-44. PubMed ID: 22950386
[TBL] [Abstract][Full Text] [Related]
26. Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field).
Oxenreiter MM; Lane AM; Aronow MB; Shih H; Trofimov AV; Kim IK; Gragoudas ES
Br J Ophthalmol; 2022 Apr; 106(4):518-521. PubMed ID: 33355171
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy for recurrent hyphema after proton beam radiotherapy of iris melanoma.
Trichopoulos N; Damato B
Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1573-5. PubMed ID: 17429673
[TBL] [Abstract][Full Text] [Related]
28. Clinical Outcomes of Proton Beam Therapy for Choroidal Melanoma at a Single Institute in Korea.
Kim TW; Choi E; Park J; Shin DH; Jung SK; Seok S; Cho KH; Kim JY; Kim DY; Kim TH; Suh YK; Kim YJ; Moon SH
Cancer Res Treat; 2018 Apr; 50(2):335-344. PubMed ID: 28421723
[TBL] [Abstract][Full Text] [Related]
29. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.
Shields CL; Naseripour M; Shields JA; Freire J; Cater J
Am J Ophthalmol; 2003 May; 135(5):648-56. PubMed ID: 12719072
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
[TBL] [Abstract][Full Text] [Related]
31. Transpalpebral proton beam radiotherapy of choroidal melanoma.
Konstantinidis L; Roberts D; Errington RD; Kacperek A; Heimann H; Damato B
Br J Ophthalmol; 2015 Feb; 99(2):232-5. PubMed ID: 25138766
[TBL] [Abstract][Full Text] [Related]
32. [Endoresection following proton beam irradiation of large uveal melanomas].
Bechrakis NE; Höcht S; Martus P; Kreusel KM; Heese J; Foerster MH
Ophthalmologe; 2004 Apr; 101(4):370-6. PubMed ID: 15067418
[TBL] [Abstract][Full Text] [Related]
33. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
[TBL] [Abstract][Full Text] [Related]
34. Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma.
Verma V; Mehta MP
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e17-27. PubMed ID: 26915706
[TBL] [Abstract][Full Text] [Related]
35. Long-term results of proton beam irradiated uveal melanomas.
Gragoudas ES; Seddon JM; Egan K; Glynn R; Munzenrider J; Austin-Seymour M; Goitein M; Verhey L; Urie M; Koehler A
Ophthalmology; 1987 Apr; 94(4):349-53. PubMed ID: 3035451
[TBL] [Abstract][Full Text] [Related]
36. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.
Polishchuk AL; Mishra KK; Weinberg V; Daftari IK; Nguyen JM; Cole TB; Quivey JM; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):91-97. PubMed ID: 27838186
[TBL] [Abstract][Full Text] [Related]
37. Visual Outcomes of Parapapillary Uveal Melanomas Following Proton Beam Therapy.
Thariat J; Grange JD; Mosci C; Rosier L; Maschi C; Lanza F; Nguyen AM; Jaspart F; Bacin F; Bonnin N; Gaucher D; Sauerwein W; Angellier G; Hérault J; Caujolle JP
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):328-335. PubMed ID: 27084650
[TBL] [Abstract][Full Text] [Related]
38. Long-term cosmetic outcomes and toxicities of proton beam therapy compared with photon-based 3-dimensional conformal accelerated partial-breast irradiation: a phase 1 trial.
Galland-Girodet S; Pashtan I; MacDonald SM; Ancukiewicz M; Hirsch AE; Kachnic LA; Specht M; Gadd M; Smith BL; Powell SN; Recht A; Taghian AG
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):493-500. PubMed ID: 24880212
[TBL] [Abstract][Full Text] [Related]
39. Lack of radiation maculopathy after palladium-103 plaque radiotherapy for iris melanoma.
Yousef YA; Finger PT
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1107-12. PubMed ID: 22172910
[TBL] [Abstract][Full Text] [Related]
40. Trabeculectomy in patients with uveal melanoma after proton beam therapy.
Riechardt AI; Cordini D; Rehak M; Hager A; Seibel I; Böker A; Gundlach E; Heufelder J; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1379-85. PubMed ID: 26960442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
